By: Erin Brady
After the publication of a Nature Medicine study showing that circular RNAs (circRNAs) in the blood can forecast Alzheimer’s symptom risk, Circular Genomics has introduced CircPATH, a platform for discovering and validating circRNA biomarkers.











